Intel
INTC
Salesforce
CRM
Microsoft
MSFT
Advanced Micro Devices
AMD
Cisco
CSCO
US Stock MarketDetailed Quotes
MYCOF Mydecine Innovations
- 0.005100
- -0.002750-35.03%
15min DelayTrading Dec 12 12:54 ET
314.95KMarket Cap-0.04P/E (TTM)
0.006350High0.003800Low4.03KVolume0.003800Open0.007850Pre Close21.01Turnover0.05%Turnover RatioLossP/E (Static)61.76MShares0.08462052wk High-0.03P/B41.57KFloat Cap0.00010052wk Low--Dividend TTM8.15MShs Float110.000000Historical High--Div YieldTTM32.48%Amplitude0.000100Historical Low0.005000Avg Price1Lot Size
Mydecine Innovations Key Stats
EPS
According to the latest financial report of Mydecine Innovations, the latest earnings per share (TTM) for the company is -0.03. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CAD
Quarterly
Loading...
FCF
Interested in knowing about Mydecine Innovations's free cash flow? The latest report shows it as 46.57K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: CAD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Mydecine Innovations shows that the company's current ratio is 0.01, indicating healthy liquidity.
Currency: CAD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Mydecine Innovations, the quick ratio is 0.01, indicating that the company can meet its short-term debt obligations.
Currency: CAD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Mydecine Innovations? The latest ROE figure is -5.15K%, indicating that the company has stable profitability.
Currency: CAD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Mydecine Innovations, the total asset return on investment (ROA) is -1.18K%.
Currency: CAD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Mydecine Innovations's latest financial report to see how their gross margin is doing - currently at 21.94%.
Currency: CAD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Mydecine Innovations, the net profit margin is -145.22K%, which is a good sign for its profitability.
Currency: CAD
Quarterly
Loading...
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
